Wiseguyreports

 Summary - A new market study, titled “Global Irritable Bowel Syndrome Treatment Market Research Report Forecast to 2023 ” has been featured on WiseGuyReports.   Irritable bowel syndrome (IBS) is a global issue, with 5% to 15% of the total population experiencing symptoms that would satisfy the definition of IBS. This condition is characterized by stomach pain and distress with altered bowel habits in the absence of any other mechanical, inflammatory, or biochemical clarification for these symptoms. The growing prevalence of anxiety, strong drug pipeline, and increasing prevalence of depression are expected to drive the market growth. In a systematic review of the global prevalence of IBS, in 2015 Lovell and Ford documented a collective prevalence of 11% with all regions of the world anguishing from this disorder at parallel rates. However, stringent government regulations and limited patient satisfaction with IBS treatment provided by healthcare professionals may hamper the...

 Summary - A new market study, titled “Global Irritable Bowel Syndrome Treatment Market Research Report Forecast to 2023 ” has been featured on WiseGuyReports. Irritable bowel syndrome (IBS) is a global issue, with 5% to 15% of the total population experiencing symptoms that would satisfy the definition of IBS. This condition is characterized by stomach pain and distress with altered bowel habits in the absence of any other mechanical, inflammatory, or biochemical clarification for these symptoms. The growing prevalence of anxiety, strong drug pipeline, and increasing prevalence of depression are expected to drive the market growth. In a systematic review of the global prevalence of IBS, in 2015 Lovell and Ford documented a collective prevalence of 11% with all regions of the world anguishing from this disorder at parallel rates. However, stringent government regulations and limited patient satisfaction with IBS treatment provided by healthcare professionals may hamper the growth...